Advertisement

Global health diagnostics firm Daktari Diagnostics Inc. has landed $1.8 million in equity financing, according to a filing with the U.S. Securities and Exchange Commission.

The Cambridge-based company focuses on delivering diagnostic test results to doctors and patients. Its first product is an HIV point-of-care test that is designed to perform low-cost CD4 white blood cell counts to guide treatment. Daktari Diagnostics intends to bring the CD4 counter to global sites that have access to life-saving drugs but cannot begin or monitor treatment due to inadequate diagnostics.

SOURCE

Advertisement
Advertisement